NRX Pharmaceuticals: Of The Current Report On Form 8k Of Nrx Pharmaceuticals, Inc. (the Company ) Originally Filed With The Securities And Exchange Commission On November 21, 2023 (the Original Report ). This Amendment No. 1 Is Being Filed To Include The Letter Issued By Kpmg Llp ( Kpmg ), On November 21, 2023, And Received By The Company On The Same Date, With Regard To The Company S Dismissal Of Kpmg As The Company S Independent Registered Public Accounting Firm, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  NRX Pharmaceuticals Inc (formerly Big Rock Partners Acquisition Corp)
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***